Bever Pharmaceutical Pte. Ltd., Pharmstandard deal

Pharmstandard said it has agreed to acquire Bever for $590 million comprised of $542 million in global depositary receipts (GDRs) and $48 million in cash. The acquisition is subject to shareholder app...